Fukuda Denshi Co., Ltd. Share Price

Equities

6960

JP3806000000

Advanced Medical Equipment & Technology

Market Closed - Japan Exchange 11:30:00 31/05/2024 am IST 5-day change 1st Jan Change
6,180 JPY +0.16% Intraday chart for Fukuda Denshi Co., Ltd. -2.37% -16.15%

Financials

Sales 2022 13TCr 84Cr 7TCr Sales 2023 13TCr 86Cr 7.14TCr Capitalization 13TCr 82Cr 6.84TCr
Net income 2022 1.62TCr 10Cr 859.79Cr Net income 2023 1.73TCr 11Cr 916.1Cr EV / Sales 2022 0.43 x
Net cash position 2022 6.07TCr 39Cr 3.22TCr Net cash position 2023 6.48TCr 41Cr 3.44TCr EV / Sales 2023 0.48 x
P/E ratio 2022
7.28 x
P/E ratio 2023
7.47 x
Employees 3,382
Yield 2022
2.05%
Yield 2023
2.58%
Free-Float 53.3%
More Fundamentals * Assessed data
Dynamic Chart
Fukuda Denshi Co., Ltd Announces Notice on Shareholder Proposal CI
Fukuda Denshi Co., Ltd. Revises Dividend Guidance for the Year Ending March 31, 2024 CI
Fukuda Denshi Co., Ltd. Revises Consolidated Earnings Guidance for the Year Ending March 31, 2024 CI
Fukuda Denshi Co., Ltd. Announces Special Dividend for the Year Ended March 31, 2024 CI
Fukuda Denshi Co., Ltd. Revises Year End Dividend Guidance for the Fiscal Year Ending March 31, 2024 CI
Fukuda Denshi Co., Ltd. Provides Special Dividend Guidance for the Year Ending March 31, 2024 CI
Fukuda Denshi Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2024 CI
Fukuda Denshi Co., Ltd. Revises Dividend Guidance for the Fiscal Year Ending March 31, 2024 CI
Senzime Licensee Fukuda Denshi Launches Integrated Tetragraph Module in Japanese Market CI
Tranche Update on Fukuda Denshi Co., Ltd.'s Equity Buyback Plan announced on January 31, 2024. CI
Fukuda Denshi Co., Ltd.'s Equity Buyback announced on January 31, 2024, has closed with 1,428,700 shares, representing 4.72% for ¥11,258.16 million. CI
Fukuda Denshi Co., Ltd. announces an Equity Buyback for 2,000,000 shares, representing 6.61% for ¥15,760 million. CI
Fukuda Denshi Co., Ltd. authorizes a Buyback Plan. CI
Fukuda Denshi’s Attributable Profit up 20.8% in Fiscal H1 MT
Fukuda Denshi Co., Ltd. Provides Ordinary Dividend Guidance for the Ending March 31, 2024 CI
More news
1 day+0.16%
1 week-2.37%
1 month-5.65%
3 months-13.93%
6 months-7.07%
Current year-16.15%
More quotes
1 week
6 080.00
Extreme 6080
6 420.00
1 month
6 050.00
Extreme 6050
6 950.00
Current year
6 050.00
Extreme 6050
8 740.00
1 year
4 385.00
Extreme 4385
8 740.00
3 years
3 470.00
Extreme 3470
8 740.00
5 years
3 180.00
Extreme 3180
8 740.00
10 years
2 680.00
Extreme 2680
8 740.00
More quotes
Managers TitleAgeSince
President 72 01/80/01
Chairman 79 01/68/01
Director/Board Member 55 01/98/01
Members of the board TitleAgeSince
Director/Board Member 74 01/22/01
Chairman 79 01/68/01
Director/Board Member 69 01/78/01
More insiders
Date Price Change Volume
31/24/31 6,180 +0.16% 48,500
30/24/30 6,170 +0.49% 23,900
29/24/29 6,140 +0.66% 17,300
28/24/28 6,100 -1.29% 14,500
27/24/27 6,180 -2.37% 21,100

Delayed Quote Japan Exchange, May 31, 2024 at 11:30 am IST

More quotes
FUKUDA DENSHI CO., LTD. is a Japan-based company mainly engaged in manufacture, purchase and sale of medical electronic equipment. The Company operates in four business segments. The Biopsy Device segment mainly involves in the manufacture, trading and sales of electrocardiographs, ultrasound diagnostic imaging equipment, automated hemocytometers, etc. The Biological Information Monitoring segment involves in the manufacture, trading and sale of biological information monitors. The Therapy Apparatus segment involves in the manufacture, trading and sale of defibrillators, ventilators, pacemakers, catheters, home rental business, etc. The Consumable Supplies and Others segment provides the consumable goods of equipment for all segments as well as repair and maintenance services.
More about the company